Meridian Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.5M | Buy |
77,358
+954
| +1% | +$205K | 0.6% | 30 |
|
|
2026
Q1 | $16.6M | Buy |
76,404
+1,206
| +2% | +$268K | 0.58% | 32 |
|
|
2025
Q4 | $17.2M | Sell |
75,198
-450
| -0.6% | -$103K | 0.6% | 33 |
|
|
2025
Q3 | $17.5M | Sell |
75,648
-1,118
| -1% | -$228K | 0.67% | 27 |
|
|
2025
Q2 | $14.2M | Sell |
76,766
-1,053
| -1% | -$196K | 0.61% | 29 |
|
|
2025
Q1 | $16.3M | Buy |
77,819
+5,530
| +8% | +$1.08M | 0.79% | 18 |
|
|
2024
Q4 | $12.8M | Sell |
72,289
-2,589
| -3% | -$476K | 0.61% | 31 |
|
|
2024
Q3 | $14.8M | Buy |
74,878
+2,363
| +3% | +$441K | 0.73% | 24 |
|
|
2024
Q2 | $12.4M | Buy |
+72,515
| New | +$12M | 1.49% | 12 |
|
|
2024
Q1 | – | Sell |
-71,481
| Closed | -$11.1M | – | 200 |
|
|
2023
Q4 | $11.1M | Buy |
71,481
+24,996
| +54% | +$3.64M | 0.71% | 25 |
|
|
2023
Q3 | $6.93M | Buy |
46,485
+3,439
| +8% | +$505K | 0.42% | 48 |
|
|
2023
Q2 | $5.8M | Sell |
43,046
-51
| -0.1% | -$7.48K | 0.49% | 31 |
|
|
2023
Q1 | $6.87M | Buy |
43,097
+5,041
| +13% | +$771K | 0.6% | 28 |
|
|
2022
Q4 | $6.15M | Sell |
38,056
-1,072
| -3% | -$164K | 0.6% | 25 |
|
|
2022
Q3 | $5.25M | Sell |
39,128
-1,806
| -4% | -$259K | 0.56% | 28 |
|
|
2022
Q2 | $6.27M | Sell |
40,934
-3,214
| -7% | -$491K | 0.51% | 41 |
|
|
2022
Q1 | $7.16M | Sell |
44,148
-2,723
| -6% | -$396K | 0.78% | 22 |
|
|
2021
Q4 | $6.35M | Buy |
46,871
+2,069
| +5% | +$244K | 0.68% | 26 |
|
|
2021
Q3 | $4.83M | Buy |
44,802
+4,751
| +12% | +$543K | 0.6% | 30 |
|
|
2021
Q2 | $4.51M | Buy |
40,051
+5,099
| +15% | +$574K | 0.57% | 35 |
|
|
2021
Q1 | $3.78M | Sell |
34,952
-5,377
| -13% | -$575K | 0.55% | 37 |
|
|
2020
Q4 | $4.32M | Buy |
40,329
+2,635
| +7% | +$253K | 0.69% | 28 |
|
|
2020
Q3 | $3.3M | Buy |
37,694
+11,699
| +45% | +$1.1M | 0.81% | 22 |
|
|
2020
Q2 | $2.55M | Buy |
25,995
+586
| +2% | +$51.6K | 0.85% | 21 |
|
|
2020
Q1 | $1.94M | Buy |
25,409
+21,406
| +535% | +$1.82M | 0.86% | 24 |
|
|
2019
Q4 | $354K | Buy |
4,003
+169
| +4% | +$14K | 0.17% | 133 |
|
|
2019
Q3 | $290K | Buy |
3,834
+596
| +18% | +$40.9K | 0.14% | 154 |
|
|
2019
Q2 | $2.35K | Buy |
3,238
+68
| +2% | +$5.34K | 0.1% | 180 |
|
|
2019
Q1 | $255K | Buy |
3,170
+221
| +7% | +$18.1K | 0.12% | 158 |
|
|
2018
Q4 | $272K | Buy |
2,949
+805
| +38% | +$70.8K | 0.16% | 125 |
|
|
2018
Q3 | $203K | Sell |
2,144
-3,663
| -63% | -$347K | 0.09% | 161 |
|
|
2018
Q2 | $538K | Buy |
5,807
+3,273
| +129% | +$320K | 0.25% | 78 |
|
|
2018
Q1 | $240K | Sell |
2,534
-354
| -12% | -$38.9K | 0.12% | 155 |
|
|
2017
Q4 | $279K | Buy |
2,888
+35
| +1% | +$3.3K | 0.17% | 132 |
|
|
2017
Q3 | $257K | Sell |
2,853
-4,391
| -61% | -$334K | 0.16% | 136 |
|
|
2017
Q2 | $525K | Buy |
7,244
+4,114
| +131% | +$277K | 0.33% | 74 |
|
|
2017
Q1 | $204K | Buy |
+3,130
| New | +$197K | 0.12% | 159 |
|
Other funds holding ABBV
Meridian Wealth Management's ABBV Position: Q2 2026 in Review
Meridian Wealth Management increased its AbbVie (ABBV) stake by 1.2% in Q2 2026, buying an estimated $205K and bringing the position to 77,358 shares worth $19.5M. The position accounts for 0.6% of the portfolio, ranked #30.
Meridian Wealth Management first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Meridian Wealth Management held 77,358 shares of AbbVie worth $19.5M as of Q2 2026.
- Meridian Wealth Management bought 954 AbbVie shares in Q2 2026, an estimated $205K.
- AbbVie made up 0.6% of Meridian Wealth Management's portfolio in Q2 2026, its #30 holding.
- Meridian Wealth Management first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
- 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.